This reclassification would signal a recognition of the drug’s potential medical benefits and its comparatively lower risk of abuse compared to other substances.

Reports have surfaced indicating that the Biden administration is gearing up to shake up federal drug policy. The U.S. Drug Enforcement Administration (DEA) is reportedly considering reclassifying ma…